Mechanism of Hormone Peptide Activation of a GPCR: Angiotensin II Activated State of AT1R Initiated by van der Waals Attraction

We present a succession of structural changes involved in hormone peptide activation of a prototypical GPCR. Microsecond molecular dynamics simulation generated conformational ensembles reveal propagation of structural changes through key "microswitches" within human AT1R bound to native hormone. The endocrine octa-peptide angiotensin II (AngII) activates AT1R signaling in our bodies which maintains physiological blood pressure, electrolyte balance, and cardiovascular homeostasis. Excessive AT1R activation is associated with pathogenesis of hypertension and cardiovascular diseases which are treated by sartan drugs. The mechanism of AT1R inhibition by sartans has been elucidated by 2.8 Å X-ray structures, mutagenesis, and computational analyses. Yet, the mechanism of AT1R activation by AngII is unclear. The current study delineates an activation scheme initiated by AngII binding. A van der Waals "grasp" interaction between Phe8AngII with Ile2887.39 in AT1R induced mechanical strain pulling Tyr2927.43 and breakage of critical interhelical H-bonds, first between Tyr2927.43 and Val1083.32 and second between Asn1113.35 and Asn2957.46. Subsequently changes are observed in conserved microswitches DRYTM3, Yx7K(R)TM5, CWxPTM6, and NPxxYTM7 in AT1R. Activating the microswitches in the intracellular region of AT1R may trigger formation of the G-protein binding pocket as well as exposure of helix-8 to cytoplasm. Thus, the active-like conformation of AT1R is initiated by the van der Waals interaction of Phe8AngII with Ile2887.39, followed by systematic reorganization of critical interhelical H-bonds and activation of microswitches.

[1]  Tomohiro Nishizawa,et al.  Activation mechanism of endothelin ETB receptor by endothelin-1 , 2016, Nature.

[2]  P. Reeves,et al.  Highly conserved tyrosine stabilizes the active state of rhodopsin , 2010, Proceedings of the National Academy of Sciences.

[3]  S. Mitaku,et al.  Identification of G protein‐coupled receptor genes from the human genome sequence , 2002, FEBS letters.

[4]  A. Hallberg,et al.  A selective AT2 receptor ligand with a gamma-turn-like mimetic replacing the amino acid residues 4-5 of angiotensin II. , 2004, Journal of medicinal chemistry.

[5]  S. Eguchi,et al.  Angiotensin II signal transduction through the AT1 receptor: novel insights into mechanisms and pathophysiology. , 2007, Clinical science.

[6]  M. Babu,et al.  Molecular signatures of G-protein-coupled receptors , 2013, Nature.

[7]  D. Duprez.  Role of the renin–angiotensin–aldosterone system in vascular remodeling and inflammation: a clinical review , 2006, Journal of hypertension.

[8]  Stephen M. Husbands,et al.  Structural insights into μ-opioid receptor activation , 2015, Nature.

[9]  R. Leduc,et al.  Structure of the Human Angiotensin II Type 1 (AT1) Receptor Bound to Angiotensin II from Multiple Chemoselective Photoprobe Contacts Reveals a Unique Peptide Binding Mode* , 2013, The Journal of Biological Chemistry.

[10]  Aashish Manglik,et al.  Propagation of conformational changes during μ-opioid receptor activation , 2015, Nature.

[11]  S. W. Lin,et al.  Specific tryptophan UV-absorbance changes are probes of the transition of rhodopsin to its active state. , 1996, Biochemistry.

[12]  Graham R. Smith,et al.  Setting up and optimization of membrane protein simulations , 2002, European Biophysics Journal.

[13]  S. Fluharty,et al.  Identification of structural determinants for G protein-independent activation of mitogen-activated protein kinases in the seventh transmembrane domain of the angiotensin II type 1 receptor. , 2006, Molecular endocrinology.

[14]  Hugh Rosen,et al.  Crystal Structure of a Lipid G Protein–Coupled Receptor , 2012, Science.

[15]  M. Bouvier,et al.  Differential β-Arrestin–Dependent Conformational Signaling and Cellular Responses Revealed by Angiotensin Analogs , 2012, Science Signaling.

[16]  David E. Gloriam,et al.  Pharmacogenomics of GPCR Drug Targets , 2018, Cell.

[17]  K. Garcia,et al.  Adrenaline-activated structure of the β2-adrenoceptor stabilized by an engineered nanobody , 2013, Nature.

[18]  J. Wess,et al.  Activation and allosteric modulation of a muscarinic acetylcholine receptor , 2013, Nature.

[19]  Kalyan C. Tirupula,et al.  Long Range Effect of Mutations on Specific Conformational Changes in the Extracellular Loop 2 of Angiotensin II Type 1 Receptor* , 2012, The Journal of Biological Chemistry.

[20]  R. Stevens,et al.  High-Resolution Crystal Structure of an Engineered Human β2-Adrenergic G Protein–Coupled Receptor , 2007, Science.

[21]  Arvind Ramanathan,et al.  Protein conformational populations and functionally relevant substates. , 2014, Accounts of chemical research.

[22]  S. Karnik,et al.  Domain coupling in GPCRs: the engine for induced conformational changes. , 2012, Trends in pharmacological sciences.

[23]  Sébastien Boutet,et al.  Structure of the Angiotensin Receptor Revealed by Serial Femtosecond Crystallography , 2015, Cell.

[24]  L. Gelb,et al.  A Monte Carlo simulation study of methane clathrate hydrates confined in slit-shaped pores. , 2012, The journal of physical chemistry. B.

[25]  S. Miura,et al.  Constitutively active mutant N111G of angiotensin II type 1 (AT(1)) receptor induces homologous internalization through mediation of AT(1)-receptor antagonist. , 2009, Journal of pharmacological sciences.

[26]  Michael F. Brown,et al.  Sequential rearrangement of interhelical networks upon rhodopsin activation in membranes: the Meta II(a) conformational substate. , 2010, Journal of the American Chemical Society.

[27]  F. Lightstone,et al.  A Comprehensive Docking and MM/GBSA Rescoring Study of Ligand Recognition upon Binding Antithrombin , 2017, Current topics in medicinal chemistry.

[28]  B. Kobilka.  G protein coupled receptor structure and activation. , 2007, Biochimica et biophysica acta.

[29]  G. Marshall,et al.  Interactions between Conserved Residues in Transmembrane Helices 2 and 7 during Angiotensin AT1 Receptor Activation , 2006, Chemical biology & drug design.

[30]  P. Corvol,et al.  Mutation of Asp74 of the rat angiotensin II receptor confers changes in antagonist affinities and abolishes G-protein coupling. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[31]  Viktor Hornak,et al.  Location of Trp265 in metarhodopsin II: implications for the activation mechanism of the visual receptor rhodopsin. , 2006, Journal of molecular biology.

[32]  Pierre Lavigne,et al.  Critical Hydrogen Bond Formation for Activation of the Angiotensin II Type 1 Receptor* , 2012, The Journal of Biological Chemistry.

[33]  Albert C. Pan,et al.  Activation mechanism of the β2-adrenergic receptor , 2011, Proceedings of the National Academy of Sciences.

[34]  Khuraijam Dhanachandra Singh,et al.  Divergent Spatiotemporal Interaction of Angiotensin Receptor Blocking Drugs with Angiotensin Type 1 Receptor , 2017, J. Chem. Inf. Model..

[35]  S. Foord.  Receptor classification: post genome. , 2002, Current opinion in pharmacology.

[36]  M. Rudd,et al.  Structural Basis for Selectivity and Diversity in Angiotensin II Receptors , 2017, Nature.

[37]  D. Worcester,et al.  Hydrostatic pressure induces hydrocarbon chain interdigitation in single-component phospholipid bilayers. , 1986, Biochemistry.

[38]  Raymond C. Stevens,et al.  Structural Basis for Ligand Recognition and Functional Selectivity at Angiotensin Receptor*♦ , 2015, The Journal of Biological Chemistry.

[39]  Krzysztof Palczewski,et al.  The Significance of G Protein-Coupled Receptor Crystallography for Drug Discovery , 2011, Pharmacological Reviews.

[40]  X. P. Liu,et al.  The active state of the AT1 angiotensin receptor is generated by angiotensin II induction. , 1996, Biochemistry.

[41]  R. Lefkowitz,et al.  Angiotensin II–Stimulated Signaling Through G Proteins and β-Arrestin , 2005, Science's STKE.

[42]  G R Marshall,et al.  Three-dimensional recognition requirements for angiotensin agonists: a novel solution for an old problem. , 1993, Biochemical and biophysical research communications.

[43]  C. Nahmias,et al.  G-protein coupled receptors of the renin-angiotensin system: new targets against breast cancer? , 2015, Front. Pharmacol..

[44]  David E. Gloriam,et al.  Trends in GPCR drug discovery: new agents, targets and indications , 2017, Nature Reviews Drug Discovery.

[45]  B. Maigret,et al.  Mutation of Asn111 in the Third Transmembrane Domain of the AT1A Angiotensin II Receptor Induces Its Constitutive Activation* , 1997, The Journal of Biological Chemistry.

[46]  Serdar Durdagi,et al.  Antihypertensive Drug Valsartan in Solution and at the AT1 Receptor: Conformational Analysis, Dynamic NMR Spectroscopy, in Silico Docking, and Molecular Dynamics Simulations , 2009, J. Chem. Inf. Model..

[47]  R. Leduc,et al.  The tyrosine within the NPXnY motif of the human angiotensin II type 1 receptor is involved in mediating signal transduction but is not essential for internalization. , 1996, Molecular pharmacology.

[48]  Diwakar Shukla,et al.  Markov State Models Provide Insights into Dynamic Modulation of Protein Function , 2015, Accounts of chemical research.

[49]  B. Wu,et al.  Structural studies of G protein‐coupled receptors , 2016, IUBMB life.

[50]  R. Leduc,et al.  The constitutively active N111G-AT1 receptor for angiotensin II maintains a high affinity conformation despite being uncoupled from its cognate G protein Gq/11alpha. , 2003, Endocrinology.

[51]  G. Marshall,et al.  Conformational analysis of two cyclic analogs of angiotensin: implications for the biologically active conformation. , 1994, Biochemistry.

[52]  B. Trzaskowski,et al.  Action of Molecular Switches in GPCRs - Theoretical and Experimental Studies , 2012, Current medicinal chemistry.

[53]  S. Karnik,et al.  The Docking of Arg2 of Angiotensin II with Asp281 of AT1 Receptor Is Essential for Full Agonism (*) , 1995, The Journal of Biological Chemistry.

[54]  S. Miura,et al.  Role of Aromaticity of Agonist Switches of Angiotensin II in the Activation of the AT1 Receptor* , 1999, The Journal of Biological Chemistry.

[55]  K. Palczewski,et al.  Activation of G protein-coupled receptors: beyond two-state models and tertiary conformational changes. , 2008, Annual review of pharmacology and toxicology.

[56]  S. Miura,et al.  Constitutive Activation of Angiotensin II Type 1 Receptor Alters the Orientation of Transmembrane Helix-2* , 2002, The Journal of Biological Chemistry.

[57]  Dan Li,et al.  Revealing the favorable dissociation pathway of type II kinase inhibitors via enhanced sampling simulations and two-end-state calculations , 2015, Scientific Reports.

[58]  David E. Gloriam,et al.  Seven evolutionarily conserved human rhodopsin G protein‐coupled receptors lacking close relatives , 2003, FEBS letters.

[59]  H. Schiöth,et al.  The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints. , 2003, Molecular pharmacology.

[60]  Kalyan C. Tirupula,et al.  International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli , 2015, Pharmacological Reviews.

[61]  P. Várnai,et al.  Signaling events activated by angiotensin II receptors: what goes before and after the calcium signals. , 1998, Endocrine research.

[62]  P. Reeves,et al.  G Protein-Coupled Receptors Contain Two Conserved Packing Clusters. , 2017, Biophysical journal.

[63]  B. Honig,et al.  A hierarchical approach to all‐atom protein loop prediction , 2004, Proteins.

[64]  Pierre Lavigne,et al.  Constitutive Activation of the Angiotensin II Type 1 Receptor Alters the Spatial Proximity of Transmembrane 7 to the Ligand-binding Pocket* , 2003, Journal of Biological Chemistry.

[65]  S. Nagamani,et al.  Pharmacophore filtering and 3D-QSAR in the discovery of new JAK2 inhibitors. , 2011, Journal of molecular graphics & modelling.

[66]  K. Bernstein,et al.  Tyrosine Kinase Activation by the Angiotensin II Receptor in the Absence of Calcium Signaling* , 2001, The Journal of Biological Chemistry.

[67]  K. Wüthrich,et al.  Allosteric Coupling of Drug Binding and Intracellular Signaling in the A2A Adenosine Receptor , 2018, Cell.

[68]  P. Scheerer,et al.  Conserved Tyr223(5.58) plays different roles in the activation and G-protein interaction of rhodopsin. , 2011, Journal of the American Chemical Society.

[69]  Oliver P. Ernst,et al.  Crystal structure of metarhodopsin II , 2011, Nature.

[70]  A. J. Venkatakrishnan,et al.  Diverse activation pathways in class A GPCRs converge near the G-protein-coupling region , 2016, Nature.

[71]  S. Rasmussen,et al.  The structure and function of G-protein-coupled receptors , 2009, Nature.

[72]  C. Altenbach,et al.  High-resolution distance mapping in rhodopsin reveals the pattern of helix movement due to activation , 2008, Proceedings of the National Academy of Sciences.

[73]  S. Karnik,et al.  Constitutive activity in the angiotensin II type 1 receptor: discovery and applications. , 2014, Advances in pharmacology.

[74]  S. Karnik,et al.  Interaction of Phe8 of Angiotensin II with Lys199 and His256 of AT1 Receptor in Agonist Activation (*) , 1995, The Journal of Biological Chemistry.

[75]  Tyuji Hoshino,et al.  Computational and statistical study on the molecular interaction between antigen and antibody. , 2014, Journal of molecular graphics & modelling.

[76]  Constantinos Potamitis,et al.  Insights into AT1 Receptor Activation through AngII Binding Studies , 2013, J. Chem. Inf. Model..

[77]  David E. Gloriam,et al.  G Protein- and Agonist-Bound Serotonin 5-HT2A Receptor Model Activated by Steered Molecular Dynamics Simulations , 2011, J. Chem. Inf. Model..

[78]  D. Kliger,et al.  Deriving reaction mechanisms from kinetic spectroscopy. Application to late rhodopsin intermediates. , 1997, Biophysical journal.

[79]  A. Leslie,et al.  Agonist-bound adenosine A2A receptor structures reveal common features of GPCR activation , 2011, Nature.

[80]  S. Karnik,et al.  Ligand-specific Conformation of Extracellular Loop-2 in the Angiotensin II Type 1 Receptor* , 2010, The Journal of Biological Chemistry.

[81]  M. Lew,et al.  Side-chain substitutions within angiotensin II reveal different requirements for signaling, internalization, and phosphorylation of type 1A angiotensin receptors. , 2002, Molecular pharmacology.

[82]  S. Miura,et al.  TM2-TM7 Interaction in Coupling Movement of Transmembrane Helices to Activation of the Angiotensin II Type-1 Receptor* , 2003, The Journal of Biological Chemistry.

[83]  H Gobind Khorana,et al.  Structural origins of constitutive activation in rhodopsin: Role of the K296/E113 salt bridge. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[84]  Kalyan C. Tirupula,et al.  G Protein-Coupled Receptors Directly Bind Filamin A with High Affinity and Promote Filamin Phosphorylation , 2015, Biochemistry.

[85]  P. Tchounwou,et al.  The Renin-Angiotensin-Aldosterone System in Vascular Inflammation and Remodeling , 2014, International journal of inflammation.

[86]  K. Griendling,et al.  Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system. , 2007, American journal of physiology. Cell physiology.

[87]  T. Sakmar,et al.  [9] Analysis of functional microdomains of rhodopsin , 2000 .

[88]  R. Leduc,et al.  Identification of Distinct Conformations of the Angiotensin-II Type 1 Receptor Associated with the Gq/11 Protein Pathway and the β-Arrestin Pathway Using Molecular Dynamics Simulations* , 2015, Journal of Biological Chemistry.

[89]  Matthew P. Repasky,et al.  Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. , 2004, Journal of medicinal chemistry.

[90]  K. Node,et al.  Structure-Function Basis of Attenuated Inverse Agonism of Angiotensin II Type 1 Receptor Blockers for Active-State Angiotensin II Type 1 Receptor , 2015, Molecular Pharmacology.

[91]  T. Schwartz,et al.  Differentiation between binding sites for angiotensin II and nonpeptide antagonists on the angiotensin II type 1 receptors. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[92]  Hans-Dieter Höltje,et al.  Molecular dynamics simulations of bovine rhodopsin: influence of protonation states and different membrane-mimicking environments , 2005, Journal of molecular modeling.

[93]  R. Leduc,et al.  The constitutively active N111G-AT1 receptor for angiotensin II modifies the morphology and cytoskeletal organization of HEK-293 cells. , 2005, Experimental cell research.

[94]  T. Unger.  The role of the renin-angiotensin system in the development of cardiovascular disease. , 2002, The American journal of cardiology.

[95]  Pierre Lavigne,et al.  Determining the Environment of the Ligand Binding Pocket of the Human Angiotensin II Type I (hAT1) Receptor Using the Methionine Proximity Assay* , 2005, Journal of Biological Chemistry.

[96]  S. Rasmussen,et al.  Crystal Structure of the β2Adrenergic Receptor-Gs protein complex , 2011, Nature.

[97]  Jennifer L. Knight,et al.  OPLS3: A Force Field Providing Broad Coverage of Drug-like Small Molecules and Proteins. , 2016, Journal of chemical theory and computation.

[98]  A. Shukla,et al.  Methodological advances: the unsung heroes of the GPCR structural revolution , 2015, Nature Reviews Molecular Cell Biology.

[99]  Zijian Li,et al.  New Insights into Modes of GPCR Activation. , 2018, Trends in pharmacological sciences.

[100]  K. P. Murphy,et al.  Structural energetics of peptide recognition: Angiotensin II/antibody binding , 1993, Proteins.